Verastem reports 86% six-month survival rate in pancreatic cancer trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. AMD
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Verastem reports 86% six-month survival rate in pancreatic cancer trial
VERASTEM SHS (NASDAQ: VSTM) Delayed: 6.18 +0.29 (4.92%)
Previous Close $5.89    52 Week High $2.43 
Open $5.87    52 Week Low $1.05 
Day High $6.31    P/E N/A 
Day Low $5.75    EPS $-1.79 
Volume 2,193,671